The assessment of Ki-67 as a prognostic marker in neuroendocrine tumours: a systematic review and meta-analysis.


INTRODUCTION Gastroenteropancreatic neuroendocrine tumours (GEP NETs) are classified according to tumour mitotic count or Ki-67 labelling index (LI). AIMS To systematically review articles reporting the prognosis of patients by Ki-67 LI and thereby improve the ability of clinicians to prognosticate for their patients. METHOD 265 abstracts were… (More)
DOI: 10.1136/jclinpath-2015-203340


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics